Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 October 2023 | Story Michelle Nöthling | Photo iStock
Commemorating World Mental Health Month 2023
The mental health of university students is of growing global concern.

One of the largest student mental health surveys in the world – initiated by Universities South Africa (USAf) in 2020 – found that up to 20% of university students in South Africa need mental health support. The research results also show that up to 77% of students with mental health disorders are not getting help. Contributing reasons include reluctance to seek help due to lingering stigma surrounding mental health, but also limited access. With growing demand and limited capacity, one-on-one therapy does not seem to be a sustainable solution. Some of the recommendations that stem from the report are to introduce a range of digitally based self-help interventions, to provide psychoeducation about when to access help, and to offer peer-to-peer support. This is precisely what the University of the Free State (UFS) Department of Student Counselling and Development (SCD) is now implementing. 

Coinciding with World Mental Health Awareness Month, SCD’s Road Map embodies a paradigm shift in student mental health support. “We want to capacitate students on their mental health journey. Following the Road Map, our students are now able to be active agents in their mental well-being,” says Dr Munita Dunn-Coetzee, SCD Director.

What exactly is this Road Map?

The SCD Road Map guides students to multiple sources of support. On the SCD website, students can delve into a wealth of self-help guides and toolkits that range from academic, emotional, and social well-being to personal challenges and psychological distress. In a commitment to expand the SCD reach beyond one-on-one sessions, the department is offering both in-person and online workshops and development programmes that can be accessed through Blackboard. Additionally, podcasts have been integrated into the SCD offerings to accommodate students' varying schedules and data constraints.

SCD has also partnered with the South African Depression and Anxiety Group (SADAG) to provide a 24/7 toll-free UFS Student Careline. The Careline can be reached in three ways: by calling 0800 00 6363, SMSing 43302, or emailing helpline@sadag.org. In a crisis, help is immediately activated, and assistance is sent to the student.

Another exciting aspect of SCD's Road Map¬ – which further integrates recommendations from the research report – is the shift from individual-centric interventions to group-based support. “We want to expand beyond individual therapy,” Dr Dunn-Coetzee says. “Although one-on-one therapy has an important place in mental health support, we are currently expanding to offer various support groups.” Through these circles of support, SCD aims to foster a culture of mutual learning, peer-to-peer connection, and collective well-being.

The Road Map therefore enables SCD to pivot toward a capacitating approach, equipping students to navigate their mental health journey in a truly collaborative model.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept